608 related articles for article (PubMed ID: 33290434)
21. The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans.
Toneatto D; Ismaili S; Ypma E; Vienken K; Oster P; Dull P
Hum Vaccin; 2011 Jun; 7(6):646-53. PubMed ID: 21904120
[TBL] [Abstract][Full Text] [Related]
22. A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.
Pajon R; Lujan E; Granoff DM
Vaccine; 2016 Jan; 34(5):643-649. PubMed ID: 26709637
[TBL] [Abstract][Full Text] [Related]
23. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens.
Williams JN; Weynants V; Poolman JT; Heckels JE; Christodoulides M
Vaccine; 2014 Mar; 32(11):1280-6. PubMed ID: 24486354
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
[TBL] [Abstract][Full Text] [Related]
25. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
26. A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).
Esposito S; Prymula R; Zuccotti GV; Xie F; Barone M; Dull PM; Toneatto D
Hum Vaccin Immunother; 2014; 10(7):2005-14. PubMed ID: 25424810
[TBL] [Abstract][Full Text] [Related]
27. Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them.
Holst J
Hum Vaccin; 2007; 3(6):290-4. PubMed ID: 17712231
[TBL] [Abstract][Full Text] [Related]
28. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC
Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555
[TBL] [Abstract][Full Text] [Related]
29. Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.
Buckwalter CM; Currie EG; Tsang RSW; Gray-Owen SD
J Infect Dis; 2017 May; 215(10):1590-1598. PubMed ID: 28368526
[TBL] [Abstract][Full Text] [Related]
30. Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease.
Watson PS; Novy PL; Friedland LR
Int J Infect Dis; 2019 Aug; 85():22-27. PubMed ID: 31102824
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB).
Efron A; Biolchi A; Sorhouet Pereira C; Tomei S; Campos J; De Belder D; Moscoloni MA; Santos M; Vidal G; Nocita F; Vizzotti C; Pizza M
Hum Vaccin Immunother; 2023 Dec; 19(3):2288389. PubMed ID: 38111094
[TBL] [Abstract][Full Text] [Related]
32. The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.
Masignani V; Pizza M; Moxon ER
Front Immunol; 2019; 10():751. PubMed ID: 31040844
[TBL] [Abstract][Full Text] [Related]
33. Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269.
Stella M; Giuliani M; Biolchi A; Tomei S; De Paola R; Bai X; Borrow R; Lucidarme J; La Gaetana R; Toneatto D; Pizza M; Serino L; Mori E; Giuliani MM
Hum Vaccin Immunother; 2020 Apr; 16(4):945-948. PubMed ID: 31770063
[TBL] [Abstract][Full Text] [Related]
34. Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica.
Lucidarme J; Gilchrist S; Newbold LS; Gray SJ; Kaczmarski EB; Richardson L; Bennett JS; Maiden MC; Findlow J; Borrow R
Clin Vaccine Immunol; 2013 Sep; 20(9):1360-9. PubMed ID: 23803905
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
[TBL] [Abstract][Full Text] [Related]
36. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.
Costa I; Pajon R; Granoff DM
mBio; 2014 Aug; 5(5):e01625-14. PubMed ID: 25161192
[TBL] [Abstract][Full Text] [Related]
37. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
[TBL] [Abstract][Full Text] [Related]
38. Multicomponent meningococcal serogroup B vaccine (4CMenB; Bexsero(®)): a review of its use in primary and booster vaccination.
Carter NJ
BioDrugs; 2013 Jun; 27(3):263-74. PubMed ID: 23575646
[TBL] [Abstract][Full Text] [Related]
39. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.
Oftung F; Naess LM; Wetzler LM; Korsvold GE; Aase A; Høiby EA; Dalseg R; Holst J; Michaelsen TE; Haneberg B
Infect Immun; 1999 Feb; 67(2):921-7. PubMed ID: 9916109
[TBL] [Abstract][Full Text] [Related]
40. Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis.
Haghi F; Peerayeh SN; Siadat SD; Zeighami H
Vaccine; 2012 Feb; 30(9):1710-4. PubMed ID: 22234267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
